Core Viewpoint - Beta Bionics, Inc. is set to release its first quarter 2025 financial results on May 6, 2025, after market close, followed by a conference call and webcast [1]. Company Overview - Beta Bionics, Inc. is a commercial-stage medical device company focused on developing innovative solutions for insulin-requiring individuals with diabetes [3]. - The company utilizes advanced adaptive closed-loop algorithms to enhance diabetes treatment, with its flagship product being the iLet Bionic Pancreas, the first FDA-cleared insulin delivery device that autonomously determines insulin doses [3]. Investor Relations - For investor inquiries, Blake Beber serves as the Head of Investor Relations, and can be contacted via email [4]. - Media and public relations are managed by Karen Hynes, Vice President of Marketing, who is also available for contact [4]. Webcast Information - The webcast for the financial results will be accessible on the company's website under the "Investors—Events & Presentations" section, and will be archived for future viewing [2]. - Live call access is available by dialing (888) 596-4144 with a passcode of 8363701 [2].
Beta Bionics to Announce First Quarter 2025 Financial Results on May 6, 2025